I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 32 studies | 28% ± 8% | |
| B cell | 21 studies | 26% ± 6% | |
| memory B cell | 17 studies | 25% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 15 studies | 34% ± 11% | |
| CD16-positive, CD56-dim natural killer cell, human | 15 studies | 37% ± 6% | |
| plasma cell | 13 studies | 36% ± 13% | |
| naive B cell | 13 studies | 21% ± 7% | |
| mature NK T cell | 7 studies | 24% ± 7% | |
| plasmablast | 6 studies | 47% ± 17% | |
| hematopoietic precursor cell | 5 studies | 29% ± 11% | |
| hematopoietic stem cell | 5 studies | 28% ± 5% | |
| immature B cell | 5 studies | 32% ± 14% | |
| innate lymphoid cell | 4 studies | 28% ± 10% | |
| IgA plasma cell | 4 studies | 28% ± 7% | |
| IgG plasma cell | 4 studies | 24% ± 5% | |
| non-classical monocyte | 3 studies | 25% ± 9% | |
| common myeloid progenitor | 3 studies | 40% ± 17% | |
| lymphocyte | 3 studies | 19% ± 2% | |
| precursor B cell | 3 studies | 27% ± 2% | |
| germinal center B cell | 3 studies | 25% ± 3% | |
| granulocyte monocyte progenitor cell | 3 studies | 28% ± 12% | |
| group 3 innate lymphoid cell | 3 studies | 25% ± 5% |
